FUNDACION UNIVERSITARIA SAN MARTIN
FUNDACION UNIVERSITARIA SAN MARTIN
PRESENTADO A: DOCTOR JUAN PABLO TEHELEN CARREÑO
PRESENTADO A: DOCTOR JUAN PABLO TEHELEN CARREÑO
PRESENTADO POR: AURA MARIA GOMEZ PABON
PRESENTADO POR: AURA MARIA GOMEZ PABON
ESTUDIANTE DE SEPTIMO SEMESTRE
ESTUDIANTE DE SEPTIMO SEMESTRE
SANTIAGO DE CALI,
HISTORIA CLINICA FAMILIAR
HISTORIA CLINICA FAMILIAR
# HISTORIA CLINICA:
# HISTORIA CLINICA:
2102121421021214
NOMBRE:
NOMBRE:
JOAQUIN RAMON DIAZ JOAQUIN RAMON DIAZ SALCEDOSALCEDO
ORIGEN/PROCEDENCIA:
ORIGEN/PROCEDENCIA:
LA LA UNION-VALLE UNION-VALLEDOCUMENTO DE IDENTIDAD:
DOCUMENTO DE IDENTIDAD:
CC.1112619324 CC.1112619324LUGAR DE NACIMIENTO:
LUGAR DE NACIMIENTO:
LA LA UNION-VALLE UNION-VALLEFECHA DE NACIMIENTO:
FECHA DE NACIMIENTO:
MAYO/19/1992 MAYO/19/1992NIVEL SOCIOECONOMICO:
NIVEL SOCIOECONOMICO:
ESTRATO 1 ESTRATO 1ESTADO CIVIL:
ESTADO CIVIL:
UNION LIBRE UNION LIBREESCOLARIDAD:
ESCOLARIDAD:
SEPTIMO DE SEPTIMO DE BACILLERATOBACILLERATO
PROFESION:
PROFESION:
CONSTRUCCION CONSTRUCCIONOCUPACION:
OCUPACION:
O!ICIOS VARIOS O!ICIOS VARIOSGRUPO ETNICO:
GRUPO ETNICO:
MESTIZO MESTIZORELIGION:
RELIGION:
CRISTIANA CRISTIANAINFORMANTE:
INFORMANTE:
JOAQUIN RAMON JOAQUIN RAMON DIAZ Y ESTEDIAZ Y ESTE!!ANIA DIAZ SANIA DIAZ SALCEDOALCEDO
MOTIVO DE CONSULTA:
MOTIVO DE CONSULTA:
ME SALIERON UNAS ULCERAS EN LOS "LUTEOS# MALESTAR "ENERAL#ME SALIERON UNAS ULCERAS EN LOS "LUTEOS# MALESTAR "ENERAL# !IEBRE Y VOMITO!IEBRE Y VOMITO
ENFERMEDAD ACTUAL:
ENFERMEDAD ACTUAL:
PACIENTE ADULTO JOVEN CON ANTECEDENTES DE UN TRAUMA PACIENTE ADULTO JOVEN CON ANTECEDENTES DE UN TRAUMA RAQUIMEDULAR POR ERIDA DE ARMA DE !UE"O CON PARAPLEJIA RAQUIMEDULAR POR ERIDA DE ARMA DE !UE"O CON PARAPLEJIA SECUNDARIA AL EVENTO# A NIVEL T12 ASIA-A# QUIEN IN"RESA AL SECUNDARIA AL EVENTO# A NIVEL T12 ASIA-A# QUIEN IN"RESA AL SER
SERVICIO CON UN VICIO CON UN CUADRO CLINICO APRO$IMCUADRO CLINICO APRO$IMADAMENTE CON 3 MESESADAMENTE CON 3 MESES DE EVOLUCION# CARACTERIZADO POR ULCERAS DECUBITO SACRAS DE EVOLUCION# CARACTERIZADO POR ULCERAS DECUBITO SACRAS SOBREIN!ECT
SOBREIN!ECTADAS# ASOCIADO A ADAS# ASOCIADO A ALZAS TERMICAS NO ALZAS TERMICAS NO CUANTI!ICADAS#CUANTI!ICADAS# ESCALO!RIO
ESCALO!RIOS# IPORE$IA# DIA!ORS# IPORE$IA# DIA!ORESIS# ASTENIA# ADINAMIA ESIS# ASTENIA# ADINAMIA Y VY VARIOSARIOS EPISODIOS DE EMESIS CON
EPISODIOS DE EMESIS CON CONTENIDO ALIMENTICIO.CONTENIDO ALIMENTICIO.
HISTORIA PERSONAL
HISTORIA PERSONAL
PERINATALES:
PERINATALES:
P%&'()*( )%&'+, () % U)')- V%( 19/%,/1991# ( ( *(&(, +( *( P%&'()*( )%&'+, () % U)')- V%( 19/%,/1991# ( ( *(&(, +( *( (%), # %+( )'(% &,5'&%&',)( +%)*( ( (7%%8,# )%&'+, (%), # %+( )'(% &,5'&%&',)( +%)*( ( (7%%8,# )%&'+, 5, 5%*, )%*% % *'),# () ,5'*% ",)8%, C,)*(%# &,)
5, 5%*, )%*% % *'),# () ,5'*% ",)8%, C,)*(%# &,) %+(&%+, 5(, *%%
%+(&%+, 5(, *%% % )%&( # (&'7' %&*%)&'% (:&';% , 5'(,% )%&( # (&'7' %&*%)&'% (:&';% , 5'(, 6 (( +( ;'+%.
6 (( +( ;'+%.
INFANCIA:
,% &,)<,%+, 5, = 5(,)%# 5%+( +, ,% &,)<,%+, 5, = 5(,)%# 5%+( +, (%)%# % %(%)%# % % (+%+ +( = %>, 5%+( ( (5%%,) () %, *'),# %<(&*%)+, (+%+ +( = %>, 5%+( ( (5%%,) () %, *'),# %<(&*%)+, +?*'&%()*( % %,)@% <%''% +?*'&%()*( % %,)@% <%''%. A 5%*' . A 5%*' +( (*% (+%+ ( +( (*% (+%+ ( 5%+( +(, +(5%+( +(, +( (5,)+( 5, (5,)%7''+%+( %7%)+,)?)+,, ') +(% %*, +( (5,)+( 5, (5,)%7''+%+( %7%)+,)?)+,, ') +(% %*, +( 5%%+(,# +(7'+, % (*, J,%@) 5%%+(,# +(7'+, % (*, J,%@) (%)%# +(7'(,) (5((%)%# +(7'(,) (5(8% %8% % *%7%% &,) %+( () ( (&'&%( +(+( *(5%)% (+%+ 5%% % *%7%% &,) %+( () ( (&'&%( +(+( *(5%)% (+%+ 5%% % %)*()&') +( ,%# ,*';, 5, ( &% ), ,, +'<*% %)*()&') +( ,%# ,*';, 5, ( &% ), ,, +'<*% )'>(8)'>(8 % (;% %
% (;% % &%7, &,(&*, +(%,,# %'*@% % % (&(% +( &%7, &,(&*, +(%,,# %'*@% % % (&(% +( 5(7,#5(7,# () ,%', +(
() ,%', +( % *%+(. !( (5''% *%+(. !( (5''+, &%*'%+, +, &%*'%+, 5, %+(# % (5, %+(# % ( (% +(%,%7% *,+% <*%&') &,) &%*', <(*(.
(% +(%,%7% *,+% <*%&') &,) &%*', <(*(. D(&'+'(,) '( % &('*,- ;%( 5%%
D(&'+'(,) '( % &('*,- ;%( 5%%
ADOLESCENCIA:
ADOLESCENCIA:
E) (*% (*%5% +(&'+( (*'%( +( &,(', &%)+, (*%7% &%)+, E) (*% (*%5% +(&'+( (*'%( +( &,(', &%)+, (*%7% &%)+, 5*', %+, 5,
5*', %+, 5, %% %+%5*%&')# ((( ( (*% +(&'') % *,%% %+%5*%&')# ((( ( (*% +(&'') % *, 5,( ), ( *%7% (*+'% %+(? +(&'+( ()*% % *%7%% +(+( 5,( ), ( *%7% (*+'% %+(? +(&'+( ()*% % *%7%% +(+( ,, 11 %>, &,, %+%)*( () &,)*&&',).D(7'+, % % '*%&') +(
11 %>, &,, %+%)*( () &,)*&&',).D(7'+, % % '*%&') +( %7%)+,), 5,&, &'+%+, 5,
%7%)+,), 5,&, &'+%+, 5, %+(# % %'*%+% ( *;, <(,) %+(# % %'*%+% ( *;, <(,) 5,&, (&,()+%7( , &%( , ')&'*%,) % ()*%
5,&, (&,()+%7( , &%( , ')&'*%,) % ()*% % )+, +( ;'&',% )+, +( ;'&', +( % %'%)%
+( % %'%)% %&,, % (&%, %&,, % (&%, 12 %>,. P,*(',()*( +(7'+,12 %>,. P,*(',()*( +(7'+, % % '*%&') (
% % '*%&') ( ;';@% ()*, % )+, +('&*';, ,7,# +%)*( *,+%;';@% ()*, % )+, +('&*';, ,7,# +%)*( *,+% (*% 5,&% *;,
(*% 5,&% *;, %% (%&') &,) %% (%&') &,) %+(. P%&'()*( (( %+(. P%&'()*( ((( ')'&',( ')'&', +( ;'+% (:% % *(5%)% +( ;'+% (:% % *(5%)% (+%+ &,) F*'5( (( ')(+%+ &,) F*'5( (( ') 5,*(&&') 5,*(&&')
ADULTO JOVEN:
ADULTO JOVEN:
D%)*( (*% (*%5% &,)*')% () ( )+, +('&*';, ,7, 5, , &% ( D%)*( (*% (*%5% &,)*')% () ( )+, +('&*';, ,7, 5, , &% ( &,)+()%+, % 19
&,)+()%+, % 19 %>, %>, () ( 201() ( 2011 () ( ')1 () ( ')*'**, )%&',)%*'**, )%&',)% 5()'*()&'%', &%&(%', +( 5(7,# (*;, (*()'+, +%)*( 5()'*()&'%', &%&(%', +( 5(7,# (*;, (*()'+, +%)*( +,+, %>,# +%)*( ')*%)&'% +(, (7%%8%+% %
%>,# +%)*( ')*%)&'% +(, (7%%8%+% % ),;'% J,%)% ",)8%(),;'% J,%)% ",)8%( +( 1= %>,. A
+( 1= %>,. A %'+% +( &()*, 5()'*()&'%', &,)*')% &,(*'()+, %'+% +( &()*, 5()'*()&'%', &,)*')% &,(*'()+, %&*, +('&*';, )*, % )% 7%)+% &,)<,%+% ( ( +(+'&%7%) % %&*, +('&*';, )*, % )% 7%)+% &,)<,%+% ( ( +(+'&%7%) % '&,*%&, +( (*5(<%&'()*(# () )
'&,*%&, +( (*5(<%&'()*(# () ) ()<()*%'()*, ()*( 7%)+%()<()*%'()*, ()*( 7%)+% (&'7( ;%', '5%&*, +( 7%%# ), +( (, ,&%',)?)+,( *%% (&'7( ;%', '5%&*, +( 7%%# ), +( (, ,&%',)?)+,( *%% %'(+% +(?)+,( &,, (&(%
%'(+% +(?)+,( &,, (&(% 5%%5('% %&( %5,:'%+%()*(5%%5('% %&( %5,:'%+%()*( 1= ((# +%)*( (% 5,&% 5%(% (*%7% % % (5(% +( 1= ((# +%)*( (% 5,&% 5%(% (*%7% % % (5(% +( ()+, ',# ,()*, &@*'&, 5%% % <%''% () ()(%. D(7'+, % (*( ()+, ',# ,()*, &@*'&, 5%% % <%''% () ()(%. D(7'+, % (*( ')&(, ), % 5,+'+, ;,;( % C('*, 5, %()%8% +( (*(# ,*';, ')&(, ), % 5,+'+, ;,;( % C('*, 5, %()%8% +( (*(# ,*';, 5, ( &% (*? 5, ( &% (*? (5%%+, +( (5%%+, +( <%''% ( ',. P, ( ,()*, ('+( ()<%''% ( ',. P, ( ,()*, ('+( () P%
ANTECEDENTES
P!"$%&'():
N, (((*+'-&'():
-A5()+'&(*,@% -L%5%,*,@%- T,%&,*,@% 5, '5%&*, +( %% +( <(, -P'()% '8'(+% &,,&%&') +( 5%*'), 5, '5%&*, +( %% +( <(,T%.'():
A&,,', +(+( %&( 12 %>,T!+"'():
G I5%&*, +( 7%%# &,) (&(% +( 5%%5('%F!!($%&'(:
N, (((A$&'():
N, (((O(+!('3!$4):
A+%)*( () &,)*&&')H5'"):
C,)'+, +( PSA 5('&,# %'%)% -A&,,S4.+!$'7!7:
')'&', +( ;'+% (:% % *(5%)% (+%+ &,) F*'5( 5%(% ') ')(%C,, ( (;'+()&'% () % '%() % <%''% +( 5%&'()*( (*? &,)<,%+% 5, 5%+(# (%), (5,% ( ',# ( )F&(, <%''% +( J,%@) R%) D@%8# (*? &,5(*, 5, (5,% J,%)% ",)8%( &,) '()
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
E )F&(, <%''% +( J,%@) (*? &,)<,%+, 5, (5,% J,%)% ",)8%( ',# 5, ( ,()*, ), &,);';() )*, 5, <%&*,( (:*(), ( ( , '5'+() # 5(, ', (5,% ;%) % ;''*%, % % ( ('+( &,)*%)*(()*(# J,%@) +(7'+, % (*%+, +(
5%%5('% (*%+, +( +(5(') ), %&(5*%'()*, ( '5'+( *%7%% ;( &(&(# ()(>%# % &,) ', &,) <%''% () (5(&'% &,) %+( % (%&') ( ) 5,&, +'*%)*( ,*'# &,) (5(&*, %
&@&, ,&'% ( (*% +(')*((%+, +(&(5&',)%+, (')+,( ( &, ( %(%,) ), ( 7')+%,) %5,, &%)+, , ('' *'()( )% (%&') <(*( &,) % ('') &(( () +', ) ( 5(,# ( % 5(% +( (*%+, () ( (+,# ( %%+(&( % +', ( (*? ;';, %)( &,) ''*%&',)( ( %<(% &, % 5%% 5,&(, +( %&(5*%&') 5%% (5()+( )(;, 5,(&*, %&% %+(%)*( % <%''%
ESCALA DE DEPRESION 8 ANSIEDAD DE GOLBERG
E) % (&%% +( %)'(+%+ ( 5%&'()*( J,%@) R%) D@%8 5(()*, =/9 5()*% %%*';,# () % (&%% +( +(5(') 5(()*, 6/9 5()*% %%*';%. E*, ( +(7( % %) '5%&*, 5'&,,&'% (,&',)% ( <', %&( %5,:'%+%()*( 1= (( +,)+( (*;, % '(, +( % (*(# , &% ( +(, &,, (&(% )% 5%%5('% ''*?)+,, +( %)(% +()'*';% +?*'&% % (%'8%&') +( +';(% %&*';'+%+(# %<(&*%)+, %@ +(%,, 5(,)% ,&'%# %>%+'()+, % (*, % '5,'7''+%+ +( 5,+( &,);';' &,) <%''%# % <%*% +( %5,, (,&',)% +( )') <%''%.
CICLO VITAL INDIVIDUAL
E) % %+,(&()&'% ( ()%,%'()*, , % %'*%+ @)*'% &,) ,*% 5(,)% ';( % ,;() 5%% %% '+()*'+%+. A &,5%*' &,)&(5*, ()*''()*, &,) ,*% 5(,)%# ()*(% 5,5'% '+()*'+%+ ( (( ;(( (H(%+, () ( ( ( %% 5(+( %+% % +(*(')% &,) &%'+%+ '() ( . E %+*, ,;()# J,%@) R%) D@%8 +( 24 %>, +( (+%+# ( 5(+( &,)&' ( % 5(%+, %+(&%+%()*( % %+,(&()&'% %)( &,) ;%', &(, ( %&%,) ;'+%# (*%5% () % &% +()' '+()*'+%+# (*%5% +%)*( % &% ,, +()' ,% (%&',)( %,,% ? ( &,) ;'') %&'% ( <*,# &,5(()*?)+,( ), % ,*, % 5%(% (5(*%)+, , (5%&', ,7(*';, +( &%+% ),# 5(( % % &'&)*%)&'% <,%,) )% <%''% ( %)( % +'*%)&'% ( ) <%&*, )(%*';, % ,%+, %)*()(( (*%7(CICLO VITAL FAMILIAR
F!'$'! 43 4.!3)'%3
&,) ', +( ) %>, ) 5(&,%# S%( (() (5()*';%()*(# , '5,*%)*( () (*% (*%5% ( ,% &,),'+% 7%( '+% +( )% <%''% &,) ;%,(# %, (5(*, ()*( *,+, , ')*(%)*(# %+(? ,% &,)(' )% %+(&%+% +'*'7&') +( *'(5,# (5%&', +')(,# 5%% %@ 5,+( <,% ) <*, 55(,.E 5%&'()*( *'()( ) 5)*%( +( 14/20 5%% ( '(, +( +(%,%
&(% 5, 5(')# +(7'+, % (*%+, +( 5,*%&') % ( (*%+, ('(( +(+'&%&') &,5(*% 5, 5%*( +( &'+%+, (;%)+, %&%7, % (+'+% %)*'(&%%# '() (*? % &%, ), ( 5(+( +% %
5,*(&&') )(&(%'% ( (*( ('(( *'()( %*, '(, 5%% +(%,% &(% 5, 5(')
ESCALA DE NUTRICION 9MINI NUTRITIONAL ASSESSMENT MNA
E 5%&'()*( ((( ( 5, (*%+, +( %+')%'% %*()'% %(5(8%+, % &,( (),# +(+( ( (*% 5,*%+, % *()'+, )% 5+'+% +( 5(, ')'&%*';% +(7'+, % % ''*%&') ( 5,+&(
()<((+%+ +( 7%( ( ()(, +(')*( 5, %+# ( 5%&'()*( ( ()&()*% () ) (*%+, +( % )*'&') &,) 5)*%&') (), +( 1G
INDICE DE BARTHEL
P%&'()*( ,7*;, )% 5)*%&') +( 1=/100 () (*% (&%% +( ;%,%&')# % &%5%&'+%+ <)&',)% ( ()&()*% &%%()*( &,5,(*'+%#
&%*%,?)+,, () )% +(5()+()&'% *,*%.
L% <%''% ( ) 5'% '5,*%)*( ), ,, () ( 5,&(, ()(%+, +( % ()<((+%+ '), () ( +( (%7''*%&')# 5,+(, ,7(;% )% 5)*%&') +( 9/20# , ( ')+'&% (+'%)% %*'<%&&') &,) (
<)&',)%'()*, +( % <%''%
ESCALA DE HOMES 8 RAHE
E*% (&%% '+( %&,)*(&''()*, (*(%)*( () % ;'+% ( 5(+() &,)*'7' % ( % 5(,)% +(%,() )% ()<((+%+. E %7( (*%+, () 5'') 63 5)*,# &,), +( +,% , %&,, G0 5)*,# &%7', () % %&(5*%&') +( , &,5%>(, 6G# 5%% ) *,*% +( 5)*, +( 200# 5, , &% *'()( ) '(, +( ()<((+%+ ,+(%+,.
REVISION POR SISTEMAS
•
SINTOMAS GENERALES:
((( @)*,% 7'8%, +( %+')%'% %*()'%.
•
PIEL 8 FANERAS:
5%&'()*( ((( ;(( 5?'+,# )'(% 5(()&'%+( 5(*('%# ('*(% 5?5%. •
OJOS:
)'(% +'5,5@%# (5'<,%# <,<(),# )'(% 5(+'+% +( % %+(8% ;'%. •OIDOS:
((( (&&% 7'() ,)'+, +( %*% 7%% ')*()'+%+# )'(% '5,%&'%# )'(% *'))'*# ;*',. •NARIZ:
((( 5(()*% )% %+(&%+% %+(8% ,<%*,'%# )'(% &%*%,.•
BOCA:
)'(% %<*% , %F) *'5, +( (') &(%*';% () &%;'+%+,%.
•
SISTEMA CARDIOVASCULAR
)'(% *()( +,, 5(&,+'%#5%5'*%&',)( ,*,5)(%.
•
SISTEMA RESPIRATORIO:
((( %&&(, +( *, (&()*( % ,%, +( +@%# +'<,)@%
•
SISTEMA GENITOURINARIO:
((( +'(' +(5,'&',)(•
SISTEMA
MUSCULO
ES*UELETICO
)'(% 5(()*%%*(%&',)( () % %&%# ((( +,, *,?&'&, +'<,.
E;AMEN FISICO
S'&3) <'"!$4):
TA
.12=/90FC=
GGT
3G.=KSO2
9GFR
.1GTALLA
1#60PESO
=0"GLASGO>
1=/1=INDICE DE ?ARNOFS?8 =0-G0# % ( ( ')&%5%8 +( (%'8% *,+% % %&*';'+%+( 5, ( ',# ('(( )% %'*()&'% &,)'+(%7( <(&()*( &'+%+, 5(;()*';,
CABEZA: ),,&(<%'&,# &,) 7()% '5%)*%&') 5',%# ') (',)( (;'+()*(# 5%7() %'&% '5%)*%&') ),%# 55'% ',&,'&% (H(, <,*,,*, &,)()% 5(()*(# (&(% %)'&*('&%# &,))*';% 5%5(7% ('5%'+% (+%# <,% )%%( 5((%7(# %7', '*'&,# ,,<%')( F(+% ),,&,,(%+%
CUELLO
:
;' ), +,,,,# ), ( 5%5%) %% )' %+(),5%*@%# ') ')'*%&') %# ), % +(;'%&') +( *?(%TORA; ),,(:5%)';,# '*'&,# ') (',)( *&% () 5'(# ') 5)*, +,,,,# % % 5(&') ( (,)%)*( () %7, &%5, 5,)%(# % % %&*%&') , ;('&% 5(()*(# '+, &%+'%&, @*'&, 7'() *'7%+, ') '+, ,7(%(%+,# ') ,5,
ABDOMEN P,&, *('+, %+'5,,# ') (',)( (;'+()*(# ') &'&%&') &,%*(%# 7%)+, +(5('7(# ), ( 5%5%) %% )' (%'%# +,, (;( % % 5%5%&') 5,<)+% () '5,%*', E;TREMIDADES: L()%+, &%5'% ()*,# 5, 5(()*( 5(, +7'( () '(7, ')<(',(# (5%*'&'+%+ *'5, %)&, () '(7, ')<(',(# (+(% ()(%'8%+, () % &%*, (:*('+%+( GENITOURINARIO
:
N(%*';, % % 5%5%&') +( 5)*, (*%(# ') '), +( 5%*,,@% ,7*&*';%OSTEOMUSCULAR: *,), &% &,)(;%+, 5(, %% &% +'')'+%# '5((H(:'%# 5,'7( ,*(,'('*' () (') %&%
PARACLINICOS
CUADRO EMATICO 0=/04/20 16 10/04/20 16 11/04/20 16 14/04/20 16 1G/04/20 16 19/04/20 16 20/04/ RECUENTO DE LEUCOCITOS 20.2 9.G .1 .3 9.2 6.4 NEUTRO!ILOS 91.3 6G.4 G=.= G9.6 G9. G9.G G.3 LIN!OCITOS 6.4 19.= 19. 1G.0 1=.9 16.0 19.0 MONOCITOS 1.= 9.2 2.= 1.G 2.= 2 1.= EUSINO!ILOS 0.4 0.9 1.6 1.= 1.6 2.1 1 BASO!ILOS 1 1 6 0.2 0.2 0.2 0.2 REC. DE "LOBULOS ROJOS 4.G 3. 3. 3.= 3. 3.= 3. EMO"LOBINA 9.0 G.6 G.6 G.6 G. G.3 .3 EMATOCRITO 31.2 24.9 2= 23.9 2=.= 24.1 26.G VMC 66. 66 6=.3 6G.= 6G.9 69.1 69.= CM 19.30 20.2 19.0 21.=0 21.90 20.90 21.6 CCM 2.0 30.= 30.40 31.0 31.G0 30.30 31.1 ANCO DE DISTRIB. DE LOS ERITROCITOS IDE 1=. 1=. 1=.2 16.9 1.2 19.2 19.G PLAQUETAS 3= =4 6G4 =10 =3= =03 == PCR 36G.0= 99.41 GG.G1 =4.== 2G.2G 3G.3 -E 0=/04/16 ')(, &,) )% (,,7')% +( 9.0# VCM66.# CM19# , &% ')+'&% )% %)('% '&,&'*'&% '5,&,'&%# &%% 5,+@%+(7(( % )% %)('% <(,5)'&% +( ,'() &%()&'%# ( +@% +( ((, (5,*, )% (,,7')% +( .3# 5, , &% ( <, &,5(()*, +( '(, %7%*,', <%*, <(,,
-E 0=/04/16 ')(% &,) ) &%+, (?*'&, &,) <%)&% (5(*% ')H%%*,'% +,)+( ( (;'+()&'% (&,&'*,'# )(*,'%#')<,&'*,' *,7,&'*,# PCR 36G.0# 5, <,&, ')<(&&',, % )';( +( *('+, 7%)+, 5, (&%% ,7(')<(&*%+% () (') %&%# +%)*( (*%)&'% () ( (;'&', , %&%+,( ')H%*,', <(,) +'')()+, %+%()*( ,*%)+, (5(*% <%;,%7( % % %)*'7',*(%5'%5'5(%&'')%
*%8,7%&*%&')+%'&')% 5(, ))&% (%,) % %), ),%( 5, , &% ( +(&'+' 5()+( &')+%'&')% 5, 5,'7( ,*(,'('*' %>%+'()+, % ((% ;%)&,'&')% 04/16/2016 () &*';, +( (&(&') +( 5()( ( %' A&')(*,7%&*( S55# ,*%)+, () ( %)*'7',%%
()'7( % (,5(# 5, , &% 04/1/2016 ( ')'&'% (,5( 1 &/ '; QUIMICA 0=/04/20 16 11/04/20 16 14/04/20 16 1G/04/20 16 19/04/20 16 CLORO 100 104 101 10= 103 POTASIO 3.G9 3.=G 3.10 3.39 4.0G SODIO 13G 1.3 13= 1.3 1.36 CREATINI NA 0.3 0.=3 BUN 6.9 1.90
E) 5%%&@)'&, +( &,)*, +( ((&*,'*, 5(()*, ) '5,%('% +( 3.10 5, , &% ( ')'&' %)(, &,) ',) 5%% ((*%7(&( (*( +(,+() ',) 10 && &%+% &,) , &% 5,(, (, % )';(( ),%( &,) ) ;%, +( 4.0G
-C,, ( (;'+()&'% () % (*% +( (&(&') +( (&%% ( %'%,) +, '&,,%)',
1 P(+,),% %('),% 5, , &% ( ')'&' 5'5(%&'')% *%8,7%&*% ( +(&'+' (;% %*% ( +@% G
2 S*%5,&,&& %( 5, , &% ( ')'&' &')+%'&')% (;% %*% ( +@% G
- S( ();' +'&, &*';,# 5, (&(&') 5%*';% <*'+% +( 5()(# () ( &% ( %' A&')(*,7%&*( 5 *'('*()*(# ( &% ,*, ()'7''+%+ %'%&')%#''5()( (,5()(
10/04/16 S( ( (%'8, ) 5(7% +( VI 5, %)'<(*% 5?&*'&% (:%( ')(% ') 5,*(&&') %,&'%+, % (*, )% 5+'+% +( 5(, ')'&%*';% F*'5( %+(),5%*@% ')')%( 5%&%;'&%(
DIAGNOSTICOS POR EJES:
CICLO VITAL INDIVIDUAL: A+*, ,;()
TAREA: I)*''+%
PELIGRO: A'%'()*,
LOGRO: S()*'+, +( % )%'+%+
EJE 2: CICLO VITAL FAMILIAR
FAMILIA EN E;PANSION
Fase de expansión, se inicia con el nacimiento del primer hijo, al que pueden seguir otros, Helen de 6 años y Samuel de 1 año. La aparición de nueos miem!ros en la "amilia precisa de los padres un n#mero mayor de reajustes con un eleado n#mero de responsa!ilidades ya que cam!ian las prioridades de la pareja, pro!a!lemente, nos encontremos en la "ase de adaptación m$s di"%cil que su"re la pareja, de tal "orma que uno o am!os padres de!en hacer "rente con decisión a los cam!ios necesarios para lograr una "amilia que progrese y "ormen "undamentos "irmes !asados en amor, responsa!ilidad y respeto.
&l reto en este momento consistir$ en equili!rar la pr$ctica ha!itual para el adecuado "uncionamiento "amiliar con la autonom%a, con"ian'a e independencia que reclaman los hijos a esas edades, sin perder la relación de intimidad arraigada en la pareja. ( el peligro que se deria de esta "ase es incurrir en la so!reprotección y excesio control de los hijos, que prooque un sentimiento de descon"ian'a e inseguridad e impida el proceso natural y el correcto desarrollo de los menores
FASES DE LA FAMILIA EN EXTENSION
• nacimiento del primer hijo
• permea!ilidad de agentes externos
• autonom%a, con"ian'a e independencia de los hijos • mantenimiento de la intimidad conyugal
• Peligros: so!reprotección, descuido de la relación %ntima y del amor
conyugal
EJE @: FACTORES DE RIESGO
- ?7'*, &,, ( *%7%',# %&,,',# &,), +( PSA# '(, +( <' &(% 5, 5(')# %*'*'
EJE : PROBLEMAS CLINICOS DEL PACIENTE
SECUELAS DE TRAUMARA*UIMEDULAR A NIVEL DE T12,
ASIAA
ULCERAS SACRAS SOBREINFECTADAS GRADO IV
ANEMIA MICROCITICA NORMOCROMICA
E 5%&'()*( J,%@) R%) D@%8 &,, %)*(&(+()*( '5,*%)*( %&(
%5,:'%+%()*( 1= (( <' ) *%% %'(+% 5, ('+% +( %% +( <(, % )';( +( T12- ASIA-A# &,5,(*')+,( *,*%()*( % <)&')
,*,% &,5,)()*( (),'% 5((;%+, 5%% , (()*, S4
S=#+(%)+,( ) (*%+, +( 5,*%&') +(5()+()&'%. E) ( (:%() <@'&, ( ,7(; (5%*'&'+%+ *'5, %)&, () '(7, ')<(',(# 5, , &% %
,()*, +( ((, ( ();' ,+() 5%% *(%5'% <@'&% ')(*'&%# 5%% (;'*% 5,(') +( (*,# (,% () %)% (+'+% &%'+%+ +( ;'+%
D(7'+, % (*%+, +( +(5()+()&'% <%*% +( (&,# ), ( (%'8% , &,)*,( +'&, *(%5'% &,(5,)+'()*(# (*, ''*?)+,, % &%7', +( ,)+% ;('&% &%+% ( &5( &'&, 5(+'5,)')+,, % ')<(&&',)(# )% %'()*%&') %+(&%+% ( ( 7')+( *,+, ,
((''()*, )*'&',)%(# () ( (,%% +( ')(, (5,*, )% (,,7')% () 9.0 VCM66. CM19.30 , &% ')+'&% )% %)('% '&,&'*'&% '5,&,'&% &%% 5,+@% +(7(( % )% %)('%
<(,5()'&% +( ,'() &%()&'%. E) ( ,()*, ,, (*? % &%, +( # (%)% ( (*? (7%%8%+%# % &% ), ( 5(+( +(+'&% ( *'(5,
, &'+%+, %+(&%+, 5, % &,)+'&',)( *%) 5(&%'% () ( ;';() R((( ( %5,:'%+%()*( G (( ;'()( 5(()*%)+, )% &(% () (') %&% % &%( (*%7%) '()*, *%*%+% +(+( &%% % ,()*, +( ')(, % (;'&', % &(% (*%7%) ,7(')<(&*%+%# &,) ) +'?(*, %5,:'%+%()*( +( 13 & 5,<)+'+%+ +( 10 &
5()*%# <*'+%# &,) &,)*()'+, %),%*,, &,5,', +( (,# &%'&?)+,( () (&%% %&% ,7(')<(&*%+% %+, IV
CLASIFICACION DE LAS ULCERAS POR PRESION 9UPP SEGN EL PANEL EUROPEO DE UPP
L% F&(% 5, 5(') &,)*'*() ) *'5, (5(&'% +( (',)( &%%+% 5, ) *%*,), +( ''%&') %)@)(% )*'&') *'% &,, (*%+, +(
5(') 5,,)%+% ,7( 5,')()&'% (% , &%*'%'),%. AF) ( *''8% ( *'), +( F&(% 5, +(&F7'*,# ( ( (%+,. L% (',)( ), ,, (
5,+&() () 5,'&') 5')%# '), *%7') () , 5%&'()*( &,))%+, % % '% +( (+%. C,, ( (&%)', 5',+'% ( % 5(')# ( 5(<('7(
+(),')%, &,, F&(% 5, 5('). O&() &,) %, <(&()&'% () % (+%+ %;%)8%+%# 5%&'()*( &,))%+, () &%% , % '% +( (+%# +()*'+,# &,5,(*'+, +( &,)&'()&'% % %5,, <%''%. L, '*', ?
&,5,(*'+, () ? +( 0 +( , &%, ,) %&,# *,&?)*((# )%%# %,, (:*(), *%,)(.
E <%&*, &%% 5',+'% () % )(' +( % F&(% ( % <(8% +(
&,5('). Y% (% <(8% +( &,5(') +( %*% ')*()'+%+ 5, &,*, 5(@,+, , +( 7%% ')*()'+%+ 5, %, 5(@,+, 5(+() 5,+&' &(%&',)(
&*?)(%. S,) ? ()'7( , *('+, 7&*?)(, ( F&,# 7%*%)+, 5(',)( +( 60-G0 5, 1-2 5%% <' &%7', '(;('7(. S( +(7( *,% () &()*% ( % 5(') ((&'+% ,7( ( %&, *,&?)*(( () % &%% ,5'*%%'% 5(+( %&%)8% %*% , 100-1=0 .
L, (<(&*, )(%*';, +( % 5(') 5, &,5(') ,) (:%&(7%+, () 5(()&'% +(
! F'(('%3 +(*(')% ) +%>, (5'*('% 5, ((5, *',)(, +( ?7%)%
5 H+47!7 &,)+'&',)%+, 5, % ,')% +(5,'&',)(. !%&''*% % %&(%&') +( % 5'(.
( F+4!) ("!3"4): ,) % <(8% ()(%+% 5, , *('+, %&,&,:@(, 5,<)+,. P(+() &%% % ,&') +( , ;%, F*(, /, +%>, (&?)'&, +( , *('+, 7&*?)(,.
POLIFARMACIA DE JOA*UIN DIAZ SALCEDO
PIPERACILINA TAZOBACTAM
M4(!3') 74 !(('%3
L% 5'5(%&'')% ( ) %)*'7'*'&,7(*%-%&*?'&,# 5')&'5%()*( 7%&*('&'+%. I)'7( % *(&(% F*'% (*%5% +( % @)*(' +( % 5%(+ &(% 7%&*('%)% )')+,( 5(<(()*(()*( % % 5,*(@)% +( )') % 5()'&'')% PBP (5(&@&% ( (
()&()*%) +()*, +( % 5%(+ &(% 7%&*('%)%. C,, *,+, ,
%)*'7'*'&, 7(*%-%&*?'&,# % &%5%&'+%+ +( 5'5(%&'')% 5%% ')*(<(' &,) % @)*(' +( % 5%(+ &(% PBP (+'%+% () F*'% ')*%)&'%
&,)+&( % % '' &(%. E*% '' (*? (+'%+% %*,'')% +( % 5%(+ &(%. L% (%&') ()*( PBP %*,'')% (*? &%%# 5(, ( 5,'7( ( ( %)*'7'*'&, 7(*%-%&*?'&, ')*((% &,) ) ')'7'+, +(
%*,'')%. E *%8,7%&*%# ( ) ')'7'+, '(;('7( +( % 7(*%-%&*%%%. E *%8,7%&*% (;'*% ( % 5'5(%&'')% ( +(*% 5, 7(*%-%&*%%% *'5, R'&,)+ S( II# III# IV# V# % 5()'&'')% (*%,&&'&% % 7(*%-%&*%%% +( %5', (5(&*,
I37'(!('%3 43 4$ !('43"4:
S , <( ')+'&%+, % ( () ( &*';, ( ( (%'8 % % (&(&') +( (&%% ( %' P(+,,)%%('),% # , &%( () ( %)*'7',%% +(,*%,) ( ()'7( % PIPERACILINA TAZOBACTAM#
D)') +"'$'!7! 43 4$ !('43"4:
4#= EV C/6,%E4(") )4(+37!'):
I),)',# &(<%(%# &,)<')# &,);',)(# %# 5'*,# (+(%# +'%(%# &,)*'5%&')# )?(%# ;'*,C3"!'37'(!('34):
'5(()'7''+%+ % 5'5(%&'')%# *%8,7%&*%# 5()'&'')%# &(<%,5,')%# ')'7'+,( +( 7(*%%&*%%% , % %), +( &,5,)()*(CLINDAMICINA
M4(!3') 74 !(('%3:
S( )( % % 7)'+%+( =0S +( ,'7,,% 7%&*('%),# ')'7'()+, % @)*(' +( 5,*(@)%. D(5()+'()+, +( &,)&()*%&') () ( % +( %&*%&') +( % &(5*'7''+%+ +( '&,,%)',# ( 7%&*(',*?*'&% , 7%&*('&'+%. L% &')+%'&')% ( %&*';% <()*( % )% %5'% ;%'(+%+ +( ()(
I37'(!('%3 43 4$ !('43"4:
S , <( ')+'&%+, % ( () ( &*';, +( (&(&') +( (&%% ( *%7') ( %' S5*%,&,&& %( ( ,*, ( ()'7( % % &')+%'&')%D)') +"'$'!7! 43 4$ !('43"4:
A5,% 600 # 1 %5. EV C/6,%E4(") )4(+37!'):
+,, () % %*'&%&',)(# %&'+(8 (*,%&%# *'&%'%C3"!'37'(!('34):
( ()&()*% &,5(*%()*( &,)*%')+'&%+% () 5%&'()*( &,) %)*(&(+()*( , '*,'% +( (%&&',)( %'&% %CLINDAMICINA % ')&,'&')%. E) 5%&'()*( &,) ')&'()&'% (5?*'&% , ()% ( ('(( %*% % +,'
VANCOMICINA
M4(!3') 74 !(('%3:
S,) %)*'7'*'&, +( (5(&*, (*')'+, <)+%()*%()*( % 7%&*('% "% 5,'*';%. A&*F%) % )';( +( % 7',@)*(' +( % 5%(+ &(% +( 7%&*('% () +';'')# ')'7'()+, % @)*(' +( 5(5*'+,'&%), () ()+% <%(# ) (*%+@, 5(;', %,()*, +( %&&') +( , 7(*%%&*?'&,# 5, , ( ), % ('*()&'% &8%+% )' &,5(*()&'% 5, , '*', +( )'). S(&)+%'%()*( %
;%)&,'&')% %&*%@% 5, ,*, (&%)', &,, ( % %<(&*%&') +( % 5((%7''+%+ +( % (7%)% &'*,5%?*'&% ( ')'7'&') +( % @)*(' +( ARN# ( ( ((&( +(5 ( ( <?%&, ( )' % 5(5*'+,'&%),.
I37'(!('%3 !$ !('43"4:
S , ' <( %5,5'%+, 5, % ,5(&% +( ,*(,'('*'D)') +"'$'!7! 43 4$ !('43"4
!COS.=00# 2 !COS EV C/12,%E4(") )4( +37!'):
*,7,H(7'*' ;'') 7,,%# *')'*# (,%'% , (','C3"!'37'(!('34)
'5(()'7''+%+ % (*( %)*'7'*'&, &,, &,)*%')+'&%&') (%*';% 5%&'()*( &,) ')&'()&'% ()%MEROPENEM
M4(!3') 74 !(('%3:
B%&*('&'+%. I)'7( @)*(' +( 5%(+ &(% 7%&*('%)% () 7%&*('% "% "%-# '?)+,( % 5,*(@)% +( )') % 5()'&'')%I37'(!('%3 !$ !('43"4
S , ' <( ( %+(&%+, +(7'+, % ( () ( &*';, +( % (&(&') +( 5()( ( ', A&')(*,7%&*( 5. Q( () ( %)*'7',%% ,*, ()'7''+%+ % (,5()(D)') +"'$'!7! 43 4$ !('43"4:
1 &/,%E4(") )4(+37!'):
T,7,&'*,5()'%# &(<%(%# )?(%# ;'*,# +'%(%# +,, %7+,')%# %# 5'*,# %()*, +( *%)%')%%# <,<%*%% %&%')% %)@)(% +('+,()%% ?&*'&% %)@)(%C3"!'37'(!('34):
'5(()'7''+%+ % &%7%5()'&, ( '5(()'7''+%+ %;( % -%&*?'&,.ENO;APARINA
M4(!3') 74 !(('%3 :
BPM. I)'7( % &,%%&') 5,*()&'%)+, ( (<(&*, ')'7'*,', +( % %)*'*,7')% III ,7( , <%&*,( II% $%. P,(( ((;%+% %&*';'+%+ %)*'-$% +7' %&*';'+%+ %)*'-II%I37'(!('34) !$ !('43"4
S , ' <( ( %+(&%+, &,, %)(% 5,?&*'&% 5, ( (*%+, +( (*%' +( 5%&'()*( 5,*%&')D)') +"'$'!7! 43 4$ !('43"4:
A5.40 . 1 %5. &/24 E4(") )4(+37!'):
(,%'% *,7,&'*,' *,7,&'*,5()'% (%&&',)( %'&% %()*, +( ()8'% (5?*'&% 5')&'5%()*( *%)%')%% *'&%'%# 5'*,# ('*(% (%*,%C3"!'37'(!('34):
'5(()'7''+%+ % 5')&'5', %&*';,# (5%')% , +(';%+, ')&()+, BPM. (,%'% ')*()% %&*';% , &,)+'&',)( +( %*, '(, +( (,%'% ')&()+, '&* (,?'&, (&'()*(. '*,'% +( *,7,&'*,5()'% , *,7,' 2 %'% % (),:%5%')%. E)+,&%+'*' 5*'&%.FUROSEMIDA
M4(!3') 74 !(('%3:
D'*'&, +( %%. B,(% ( '*(% +( *%)5,*( N% C - () % %% +(&()+()*( +( %% +( ()(# %()*%)+, % (:&(&') +( N%# # C% M.I37'(!('34) !$ !('43"4:
S , <( ( %+(&%+, 5,( ( 5%&'()*( *;, (+(% ()(%'8%+, () % 4 (:*('+%+( ,*, ),*%7(D)') +"'$'!7! 43 4$ !('43"4
A5. 20 # %5'&% &/12 ,%E4(") )4(+37!')
'5(()'7''+%+ % <,('+% , <,)%'+%. '5,;,('% , +('+%*%&'). I.R. %)F'&%. '5,5,*%('% ,'5,)%*('% %;(. E*%+, 5( &,%*,, &,%*,, %,&'%+, % ()&(<%,5%*@% (5?*'&%. L%&*%)&'%.
C3"!'37'(!('34):
A*(%&',)( ((&*,@*'&%# +('+%*%&') ( '5,;,('%# )';( +( &(%*')')% () %)( ((;%+% )';( +(*''&'+, () %)( ((;%+, %()*, +( ;,() +( ,')% '5,*()') ')&()+, '5,*()') ,*,*?*'&%
RANITIDINA
M4(!3') 74 !(('%3
A)*%,)'8% , (&(5*,( 2 +( % '*%')% +(% &% 5%'(*%( +( (*%,. I)'7( % (&(&') (*'%+% 7%% +( ?&. ?*'&, (+&( % 5,+&&') +( 5(5')%
I37'(!('34) !$ !('43"4:
S , <( &,, 5,*(&&') %*'&%D)') +"'$'!7! 43 4$ !('43"4:
TAB. 1=0 # 1 *%7 VO &/24 E4(") )4(+37!')
;'*,# &%%7( %7+,')%(.C3"!'37'(!('34):
'5(()'7''+%+. P,'% %+%METOCLOPRAMIDA
M4(!3') 74 !(('%3:
A)*%,)'*% +( (&(5*,( +,5%')'&, D2 +( (*'%&') ''&,&(5*,% () ( &()*, (*'&, +( % +%'5'&%+% () % %5,,)%
I37'(!('34) !$ !('43"4:
D(7'+, % ;%', (5',+', ('' +( &,)*()'+, %'()*%', 5,*(',()*( 7'',,D)') +"'$'!7! 43 4$ !('43"4:
A5. 10 # 1 %5. C/12,%E4(") )4(+37!'):
S,),()&'%# +'%(%# %*()'%# *%*,), (:*%5'%'+%(# 5%'),)',# +(5(')# '5,*()').C3"!'37'(!('%3:
(,%'% %*,')*(*')%# ,7*&&') (&?)'&% , 5(<,%&') %*,')*(*')%ION ?
M4(!3') 74 !(('%3:
C,(&&') +( % +(5(&',)( () , )';(( +( 5,*%',I37'(!('34) !$ !('43"4:
S , <( +(7'+, % )% '5,%('%# ( 5,*(',()*( <( &,('+%D)') +"'$'!7!) 43 4$ !('43"4:
I,) (':( 10 && &/,%E4(") )4(+37!'):
S'*(% +'(*';, )%(%# ;'*,# +'%(%# %(*% %7+,')% '5(&%('%.C3"!'37'(!('34):
'5(&%('%# &%'(% ( (% &%%# %&'+,' (*%7'&%ANALISIS Y PLAN
PACIENTE ADULTO JOVEN CON ANTECEDENTES DE
TRAUMARAQUIMEDULAR A NIVEL DE T12# ASIA-A# CON SECUNDARIA
PARAPLEJIA# QUIEN SE ENCUENTRA OSPITALIZADO EN EL CONTE$TO DE SINDROME !EBRIL DE ETIOLO"IA POR !OCO IN!ECCIOSO A NIVEL DE TEJIDOS BLANDOS POR ESCARAS SOBREIN!ECTADAS EN RE"ION SACRA#
CUADRO EMATICO CON !RANCA RESPUESTA IN!LAMATORIA#
NEUTRO!ILIA#TROMBOCITOSIS# LEUCOCITOSIS. EL CUAL !UE MANEJADO INICIALMENTE CON ANTIBIOTICOTERAPIA PIPERACILINATAZOBACTAM Y CLINDAMICINA COMPLETANDO ESQUEMA G/G# SE REALIZA EMO"RAMA DE CONTROL EL CUAL PRESENTA LEUCOCITOSIS RECIDIVANTE CON NEUTRO!ILIA#LIN!OCITOSIS Y PCR AUMENTADA. DECIDIO POR ENDE ESCALONAR MANEJO ANTIBIOTICO A VANCOMICINA POR POSIBLE
OSTEOMELITIS Y MEROPENEM A LA CUAL ES SENSIBLE ACINETOBACTER SSP AISLADA EN SECRECION URETRAL. AL DIA DE OY EL PACIENTE SE ENCUENTRA EMODINAMICAMENTE ESTABLE# SIN SIRS# SIN SI"NOS DE DI!ICULTAD RESPIRATORIA# LAS ESCARAS EN MEJORES CONDICIONES LIMPIAS SIN SECRECION ACTIVA AUNQUE SON PRO!UNDAS. TIENE ADEMAS UNA COLONIZACION POR ACINETOBACTER BAUMANNII EN SECRECON URETERAL. NO TIENE SI"NOS DE IN!ECCION ACTIVA# EL
EMO"RAMA ESTA DENTRO DE LOS RAN"OS NORMALES. TIENE UNA ANEMIA ASOCIADA DE TIPO !ERROPENICO POSIBLEMENE CARENCIAL.EL PACIENTYE EN EL MOMENTO CUMPLE CRITERIOS PARA SALIDA# SE DA LA ORDEN PARA LA "AMMA"RA!IA OSEA PELVICA DE SER POSITIVA DEBERA SER TRATADA POR ORTOPEDIA DE !ORMA AMBULATORIA# ORDEN DE TERAPIA !ISICA PARA TRATAR ESPASTICIDAD EN MIEMBROS IN!ERIORES#
ADEMAS SE DA ORDEN DE TERAPIA ENTEROSTOMAL# SE !ORMULA
SUPLEMENTO DE SUL!ATO !ERROSO# SE LE DAN LAS RECOMENDACONES PARA EL MANEJO DE ZONAS DE PRESION Y CUIDAOS DE PIEL.
BIBLIOGRAFA
• !%&' AS# %5( DL# B%)W%+ E# %( SL# L,), DL# J%(,) JL#
L,&%8, J# (+'*,. %',)X 5')&'5( ,< ')*()% (+'&')(. V, 1. 1G* (+.
• N(W Y, M&"%W ' 200. L,), DL# !%&' AS# %5( DL# %( SL#
J%(,) JL# L,&%8, J# (+'*,(. %',) 5')&'5', +( (+'&')% ')*()%. V, 2. 1% (+. M:'&, M&"%W' 2012.
• D?)-V%(% B%)&% R,%# R';(%-C%;'% B%)&%# !%)&,-"%(,
E)(*,. P%%&,,'&% *(%5 &,5'%)&( ') +'%7(*(. S%+ 5F7'&% M: (;'*% () % I)*()(*[. 2001 J) &'*%+, 2016 A7 26[ 43 3 233-236. D'5,)'7( () **5//WWW.&'(,.,.:/&'(,.55\ &'5*&']%**(:*^5'+S0036-36342001000300009^)(.
• V?8(8 +( P%+% JA. R('*, E5%>, +( T%5%)*( C%+'%&,. P'(
I)<,( O&'%. R(; E5 C%+',. 199144293-6.
• N'(')() M# B_ M# C,W'( M# D(:( # !''55%*, "# J,)+(% "# (* %.
"@% +( P?&*'&% C@)'&% ,7( ( +'%)*'&, *%*%'()*, +( % ')&'()&'% &%+@%&% %+%. V(') ('+%. R(; E5 C%+',. 200==39-429.
• ACS/ADA/AA. P(;()*') C%)&(# C%+',;%&% D'(%(# %)+ D'%7(*(
A C,,) A()+% <, *( A('&%) C%)&( S,&'(*# *( A('&%) D'%7(*( A,&'%*',)# %)+ *( A('&%) (%* A,&'%*',)# 2004.
• M')'*(', +( % P,*(&&') S,&'% +( C,,7'% ` !EDESALUD. "@% +(
%)(, +( % ()<((+%+ ()% &)'&% ` ERC. 200=.
• 201= ACC/AA/RS "'+(')( <, *( M%)%(()* ,< A+* P%*'()* a'*
S5%;()*'&% T%&&%+'% A R(5,* ,< *( A('&%) C,(( ,< C%+',,/A('&%) (%* A,&'%*',) T% !,&( ,) C')'&% P%&*'&( "'+(')( %)+ *( (%* R* S,&'(*.
• 201= A)*'*,7,*'& %)%(()* ') 5%*'()* )+(,')
((&*,5',,'&% 5,&(+( % E,5(%) (%* R* A,&'%*',) ERA 5,'*',) +,&()* ()+,(+ 7 *( ESC a,') ",5 T,7,'# (%* R* S,&'(* RS# %)+ A'% P%&'& (%* R*
• "@% +( P?&*'&% C@)'&% +( ACC/AA ESC 2006 ,7( ( %)(, +(
5%&'()*( &,) %'*'% ;()*'&%( % 5(;()&') +( % (*( &%+'%&% F7'*%. V(') ('+%.
• L%W( CMM# V%)+( ,) S# R,+( A# <, *( I)*()%*',)% S,&'(* ,<
5(*()',). ",7% 7+() ,< 7,,+ 5((-(%*(+ +'(%( 2001. L%)&(* 200 3G11=13`1=1.
• M%)&'% "# +( B%&( "# D,')'&8% A# C'<,;% R# !%%+ R# "(%), "#
(* %. 200G "'+(')( <, *( M%)%(()* ,< A*('% 5(*()',)# T( T% !,&( <, *( M%)%(()* ,< A*('% 5(*()',) ,< *( E,5(%) S,&'(* ,< 5(*()',) ES %)+ ,< *( E,5(%) S,&'(* ,< C%+',, ESC. J 5(*() 200G 2=110=`11G.
• L%)% !# A;(8 A# B%*'*% LE# D@%8 R# L)% M# I% S# (* %.
INTEREART I);(*'%*, ') L%*') A('&%. R' <%&*, <, %&*( ,&%+'% ')<%&*',) ') L%*') A('&% *( INTEREART L%*') A('&%) *+. C'&%*',) 200G 11=106G`10G4.
• P(+')' MT# L(;( AS# L% J# C%( TC# a%) P. T( (b(&* ,< +'(*%
5,*(') (*'&*',) ,) *( 5,(',) ,< +'%7(*'& ()% +'(%( % (*%%)%'. A)) I)*() M(+ 1996 12462G`632.
• S,W( JR# E5*(') M# !,'& ED. D'%7(*(# 5(*()',)# %)+